Risk-MaPP provides a scientific risk-based approach, based on ICH Q9 Quality Risk
Management, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance
between product quality and operator safety. Find this definition and more in the ISPE Glossary of Pharmaceutical Technology.
The Risk-MaPP approach to Quality Risk Management is documented in the ISPE Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP).
If you are involved with multi-product facilities, this document is an essential tool for you.
Opportunities to understand the “why”, “what”, and “how to use” the Guide include conferences, webinars,
training, and white papers. Educational sessions pertaining to Risk-MaPP will focus on use of the logic
diagram, how health based limits are developed, setting cleaning validation limits, risk assessments for
cross contamination, and formulating a Quality Risk Management Plan as part of a Quality System.
Risk-MaPP FAQs
ISPE has created an FAQ document dedicated to frequently asked questions on Risk-MaPP and its approach to
managing the risk of cross contamination. The first version of this document highlights questions around
limit setting which were raised during the some of the launch sessions in the fall. This document will be
updated as needed to include other frequent questions as they arise. This is a must have complement to your
Risk-MaPP guide.
Webinars
Knowledge Briefs and White Papers
Articles
Training Course

Indicates content available to ISPE members only.
Last Update: 01 April 2013